Stockscreener 앱 받기
7.35
1.08%
-0.08
시간 외 거래:
7.35
전일 마감가:
$7.43
열려 있는:
$7.35
하루 거래량:
250.81K
Relative Volume:
0.62
시가총액:
$591.61M
수익:
$27.42M
순이익/손실:
$-168.69M
주가수익비율:
-3.477
EPS:
-2.1139
순현금흐름:
$-121.04M
1주 성능:
-3.80%
1개월 성능:
-2.52%
6개월 성능:
-2.78%
1년 성능:
-5.41%
1일 변동 폭
$7.1485
$7.48
1주일 범위
$7.1485
$7.89
52주 변동 폭
$4.55
$9.73
Meiragtx Holdings Plc Stock (MGTX) Company Profile
명칭
Meiragtx Holdings Plc
전화
646-860-7985
주소
655 THIRD AVENUE, NEW YORK, NY
Compare MGTX vs VRTX, REGN, ARGX, ALNY, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MGTX
Meiragtx Holdings Plc
|
7.35 | 598.05M | 27.42M | -168.69M | -121.04M | -2.1139 |
|
VRTX
Vertex Pharmaceuticals Inc
|
458.05 | 114.72B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.45 | 78.67B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
684.50 | 42.38B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
311.10 | 41.75B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
282.72 | 31.33B | 5.36B | 287.73M | 924.18M | 2.5229 |
Meiragtx Holdings Plc Stock (MGTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-24 | 개시 | H.C. Wainwright | Buy |
| 2025-10-21 | 개시 | Raymond James | Strong Buy |
| 2024-07-31 | 재개 | Chardan Capital Markets | Buy |
| 2020-10-23 | 개시 | RBC Capital Mkts | Outperform |
| 2020-09-15 | 재개 | BofA Securities | Buy |
| 2019-09-03 | 개시 | Piper Jaffray | Overweight |
| 2019-02-27 | 재확인 | Chardan Capital Markets | Buy |
| 2018-07-03 | 개시 | Barclays | Overweight |
| 2018-07-03 | 개시 | BofA/Merrill | Buy |
모두보기
Meiragtx Holdings Plc 주식(MGTX)의 최신 뉴스
Earnings Report: Is MeiraGTx Holdings plc gaining market shareForecast Cut & AI Optimized Trading Strategy Guides - baoquankhu1.vn
Should I invest in MeiraGTx Holdings plc before earningsMarket Sentiment Review & Low Risk High Win Rate Picks - baoquankhu1.vn
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
MGTX PE Ratio & Valuation, Is MGTX Overvalued - Intellectia AI
MeiraGTx Holdings PLC $MGTX Shares Sold by Prosight Management LP - MarketBeat
MeiraGTx Holdings Stock (ISIN: US58550P1012) Faces Earnings Spotlight Amid Volatility and Analyst Op - AD HOC NEWS
Trading Systems Reacting to (MGTX) Volatility - Stock Traders Daily
MeiraGTx (NASDAQ:MGTX) Upgraded by Zacks Research to Hold Rating - MarketBeat
MeiraGTx (NASDAQ:MGTX) Sees Strong Trading VolumeTime to Buy? - MarketBeat
MeiraGTx Holdings PLC expected to post a loss of 57 cents a shareEarnings Preview - TradingView
MeiraGTx (NASDAQ:MGTX) Stock Price Down 9.6%Here's What Happened - MarketBeat
MeiraGTx (MGTX) to Release Quarterly Earnings on Thursday - Defense World
MGTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
How Meiragtx Holdings Plc (MGTX) Affects Rotational Strategy Timing - Stock Traders Daily
MeiraGTx stock rises on exclusive licensing deal with ZipBio for eye disease therapy - Investing.com Nigeria
Revenue per share of MeiraGTx Holdings Plc – FWB:328 - TradingView
Aug Weekly: Does MeiraGTx Holdings plc have consistent dividend growthAnalyst Downgrade & Risk Adjusted Buy and Sell Alerts - baoquankhu1.vn
MeiraGTx Holdings Plc (MGTX): Investor Outlook With A Potential 249% Upside - DirectorsTalk Interviews
MGTX Earning Date, Earning Analysis and Earning Prediction - Intellectia AI
Is MeiraGTx Holdings plc gaining market share2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
MeiraGTx (MGTX) CFO reports RSU vesting and tax-share withholding - Stock Titan
MeiraGTx (MGTX) CEO vests 62,500 RSUs, withholds shares for taxes - Stock Titan
MeiraGTx (MGTX) CMO reports RSU vesting and tax-share withholding on Form 4 - Stock Titan
MeiraGTx Holdings plc (MGTX) Stock Analysis: Unveiling a 254.77% Potential Upside in Gene Therapy Innovations - DirectorsTalk Interviews
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
(MGTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
MeiraGTx Holdings PLC (NASDAQ:MGTX) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
MeiraGTx inks $18.2M share purchase deal with Perceptive Advisors - MSN
MGTX Should I Buy - Intellectia AI
MeiraGTx (NASDAQ:MGTX) Trading Up 1.7%Should You Buy? - MarketBeat
Is MeiraGTx Holdings plc’s ROIC above industry averageJuly 2025 Levels & Safe Swing Trade Setups - mfd.ru
Resistance Check: Is MeiraGTx Holdings plc stock a good dividend stockPortfolio Performance Summary & Fast Gain Swing Trade Alerts - mfd.ru
Why MeiraGTx Holdings plc stock attracts high net worth investorsWeekly Stock Summary & Weekly Watchlist for Consistent Profits - mfd.ru
MeiraGTx Holdings Plc (MGTX): Investor Outlook With A Potential 263% Upside - DirectorsTalk Interviews
What is MeiraGTx Holdings plc s debt to equity ratioTrade Performance Summary & High Conviction Buy Zone Picks - mfd.ru
Risk Check: Should I invest in MeiraGTx Holdings plc before earningsTrade Exit Report & Short-Term Swing Trade Alerts - baoquankhu1.vn
Responsive Playbooks and the MGTX Inflection - Stock Traders Daily
MeiraGTx Licenses complement-targeted geographic atrophy program from ZipBio - Ophthalmology Times
Meiragtx licenses Zipbio’s gene therapies for geographic atrophy - bioworld.com
Retail Surge: Can MeiraGTx Holdings plc stock outperform in a bear marketWeekly Trading Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Resistance Check: Is Smith Micro Software Inc. gaining market shareTrade Analysis Report & Low Risk Profit Maximizing Plans - baoquankhu1.vn
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy By Investing.com - Investing.com Australia
ZipBio and MeiraGTx Enter Into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - 富途牛牛
MeiraGTx Signs Exclusive License Deal for ZipBio's Geographic Atrophy Therapies - marketscreener.com
ZipBio and MeiraGTx Enter into Exclusive License Agreement to Advance First-in-Class AAV Gene Therapy for Geographic Atrophy - Investing News Network
MeiraGTx licenses ZipBio’s AI-designed therapies for geographic atrophy - Investing.com
Winners Losers: What is the earnings history of MeiraGTx Holdings plcQuarterly Growth Report & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
What’s the outlook for MeiraGTx Holdings plc’s sectorInsider Selling & Long-Term Growth Plans - mfd.ru
Retail Surge: What is the earnings history of MeiraGTx Holdings plcTrade Ideas & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Analyst Upgrade: What is the earnings history of MeiraGTx Holdings plcPortfolio Return Report & Low Risk High Reward Ideas - baoquankhu1.vn
Meiragtx Holdings Plc (MGTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.20%
0.06%
자본화:
|
볼륨(24시간):